Evidence map›Paper›PMID 36384981›Full record

ArticleEpidemiology and infection2022

Guillain-Barré syndrome outbreak in Tapachula temporally associated with the Zika virus introduction in Southern Mexico.

Ricardo Paul Rodríguez de la Rosa, J Oggún Cano-Torres, Sonia Rosales, Anke Paula Kleinert, Arturo Gómez, Fernando George, José George, Mariana Piedad García, Gabriel Nájera-Cancino, Paola Del Carmen Guerra-de-Blas and 4 more

Open access · goldAbstract read
In one paragraph

Article in Epidemiology and infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Recognition ofBiology · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Ricardo Paul Rodríguez de la RosaHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
J Oggún Cano-TorresDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Sonia RosalesHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Anke Paula KleinertHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Arturo GómezHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Fernando GeorgeHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
José GeorgeHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Mariana Piedad GarcíaHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Gabriel Nájera-CancinoHospital Regional de Alta Especialidad, Ciudad Salud, Tapachula, Chiapas, Mexico.
Paola Del Carmen Guerra-de-BlasThe Mexican Emerging Infectious Diseases Clinical Research Network (LaRed), Mexico City, Mexico.ORCID 0000-0003-3050-6865
Pablo F Belaunzarán-ZamudioDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID 0000-0003-4775-4734
John BeigelDivision of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, MD, USA.
Guillermo Miguel Ruiz-PalaciosDepartamento de Infectología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Mexican Emerging Infectious Diseases Clinical Research Network
Hospitales Regionales de Alta Especialidad · MXInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXNational Institute of Allergy and Infectious Diseases · US

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
NCI NIH HHS 75N91019D00024NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

The Guillain-Barré syndrome (GBS) has been previously associated with Zika virus infection. We analysed the data from all the patients with GBS diagnosis that were admitted to a referral hospital, in Tapachula City during the period from January 2013 to August 2016, comparing the incidence of GBS according to the temporality of the Zika outbreak in Southern Mexico. Additionally, we described the clinical and epidemiological characteristics of the GBS patients admitted before or after the Zika outbreak. We observed a sharp increase in the number of patients hospitalised due to GBS from the time the first confirmed Zika cases appeared in Mexico. Clinically we observed GBS cases before zika outbreak had more frequently history of respiratory/gastrointestinal symptoms and GBS during zika outbreak had significantly more frequently recent history of rash/conjunctivitis. Although we cannot affirm that the increased cases of GBS have a specific aetiologic association with Zika, our results suggest that this observed outbreak of in Tapachula, might have been associated to the emerging Zika epidemic, locally and suggests that rare complications associated with acute infections (such as GBS) might be useful in the surveillance systems for emerging infections.

Indexed as

Guillain-Barre SyndromeZika VirusZika Virus InfectionDisease OutbreaksHumansMexicoClinical characteristicsGuillain-Barré syndromeoutbreakzika infection

Identifiers

PMID36384981
PMCPMC9980924
OpenAlexW4306769434

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.